PortfoliosLab logoPortfoliosLab logo
SHRT vs. LABD
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

SHRT vs. LABD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gotham Short Strategies ETF (SHRT) and Direxion Daily S&P Biotech Bear 3x Shares (LABD). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SHRT vs. LABD - Yearly Performance Comparison


2026 (YTD)202520242023
SHRT
Gotham Short Strategies ETF
-2.73%-0.91%-1.44%-5.83%
LABD
Direxion Daily S&P Biotech Bear 3x Shares
-22.25%-70.07%-21.43%-56.13%

Returns By Period

In the year-to-date period, SHRT achieves a -2.73% return, which is significantly higher than LABD's -22.25% return.


SHRT

1D
-1.51%
1M
4.54%
YTD
-2.73%
6M
-1.63%
1Y
-8.89%
3Y*
5Y*
10Y*

LABD

1D
-22.42%
1M
-7.39%
YTD
-22.25%
6M
-59.03%
1Y
-82.24%
3Y*
-55.49%
5Y*
-38.61%
10Y*
-57.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SHRT vs. LABD - Expense Ratio Comparison

SHRT has a 1.35% expense ratio, which is higher than LABD's 1.06% expense ratio.


Return for Risk

SHRT vs. LABD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SHRT
SHRT Risk / Return Rank: 33
Overall Rank
SHRT Sharpe Ratio Rank: 33
Sharpe Ratio Rank
SHRT Sortino Ratio Rank: 22
Sortino Ratio Rank
SHRT Omega Ratio Rank: 33
Omega Ratio Rank
SHRT Calmar Ratio Rank: 44
Calmar Ratio Rank
SHRT Martin Ratio Rank: 55
Martin Ratio Rank

LABD
LABD Risk / Return Rank: 11
Overall Rank
LABD Sharpe Ratio Rank: 11
Sharpe Ratio Rank
LABD Sortino Ratio Rank: 00
Sortino Ratio Rank
LABD Omega Ratio Rank: 00
Omega Ratio Rank
LABD Calmar Ratio Rank: 00
Calmar Ratio Rank
LABD Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SHRT vs. LABD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gotham Short Strategies ETF (SHRT) and Direxion Daily S&P Biotech Bear 3x Shares (LABD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SHRTLABDDifference

Sharpe ratio

Return per unit of total volatility

-0.61

-0.96

+0.34

Sortino ratio

Return per unit of downside risk

-0.84

-2.04

+1.21

Omega ratio

Gain probability vs. loss probability

0.91

0.77

+0.14

Calmar ratio

Return relative to maximum drawdown

-0.49

-0.91

+0.42

Martin ratio

Return relative to average drawdown

-0.89

-1.17

+0.28

SHRT vs. LABD - Sharpe Ratio Comparison

The current SHRT Sharpe Ratio is -0.61, which is higher than the LABD Sharpe Ratio of -0.96. The chart below compares the historical Sharpe Ratios of SHRT and LABD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SHRTLABDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.61

-0.96

+0.34

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.40

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.60

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

-0.54

+0.18

Correlation

The correlation between SHRT and LABD is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SHRT vs. LABD - Dividend Comparison

SHRT's dividend yield for the trailing twelve months is around 0.07%, less than LABD's 5.82% yield.


TTM20252024202320222021202020192018
SHRT
Gotham Short Strategies ETF
0.07%0.07%0.85%0.27%0.00%0.00%0.00%0.00%0.00%
LABD
Direxion Daily S&P Biotech Bear 3x Shares
5.82%6.67%4.68%6.13%0.53%0.00%3.94%1.75%0.81%

Drawdowns

SHRT vs. LABD - Drawdown Comparison

The maximum SHRT drawdown since its inception was -18.97%, smaller than the maximum LABD drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for SHRT and LABD.


Loading graphics...

Drawdown Indicators


SHRTLABDDifference

Max Drawdown

Largest peak-to-trough decline

-18.97%

-99.99%

+81.02%

Max Drawdown (1Y)

Largest decline over 1 year

-17.65%

-88.09%

+70.44%

Max Drawdown (5Y)

Largest decline over 5 years

-97.73%

Max Drawdown (10Y)

Largest decline over 10 years

-99.98%

Current Drawdown

Current decline from peak

-12.77%

-99.99%

+87.22%

Average Drawdown

Average peak-to-trough decline

-7.21%

-90.78%

+83.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.62%

68.46%

-58.84%

Volatility

SHRT vs. LABD - Volatility Comparison

The current volatility for Gotham Short Strategies ETF (SHRT) is 6.06%, while Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a volatility of 36.88%. This indicates that SHRT experiences smaller price fluctuations and is considered to be less risky than LABD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SHRTLABDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.06%

36.88%

-30.82%

Volatility (6M)

Calculated over the trailing 6-month period

10.51%

59.06%

-48.55%

Volatility (1Y)

Calculated over the trailing 1-year period

14.59%

87.11%

-72.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

12.66%

96.40%

-83.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

12.66%

96.40%

-83.74%